| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$94 |
Change of Director's Interest Notice
|
29 Jan 2026 1:55PM |
$1.260 |
$1.100 |
fallen by
12.70%
|
|
| Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$547 |
Daily Fund Update
|
29 Jan 2026 1:55PM |
$1.958 |
$1.640 |
fallen by
16.22%
|
|
| Jumbo Interactive Limited (JIN) ORDINARY FULLY PAID |
Consumer Discretionary |
$466 |
Company Secretary Appointment/Resignation
|
29 Jan 2026 1:54PM |
$10.320 |
$7.360 |
fallen by
28.68%
|
|
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$80 |
December 2025 Quarterly Activities Report & Appendix 4C
|
29 Jan 2026 1:54PM |
$0.010 |
$0.021 |
risen by
121.05%
|
|
AVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Avecho Biotechnology Limited's quarterly report for December 2025.
- Net cash used in operating activities was AUD 2.214 million.
- Cash and cash equivalents at the end of the period were AUD 4.663 million.
- Focus on TPM-enhanced products for human health applications.
- No cash flows from investing activities during the quarter.
- Financing activities resulted in net cash inflows of AUD 2.291 million.
- Ongoing Phase III trial for CBD TPM soft-gel capsule for insomnia treatment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$94 |
Change of Director's Interest Notice
|
29 Jan 2026 1:53PM |
$1.260 |
$1.100 |
fallen by
12.70%
|
|
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$166 |
Change in substantial holding
|
29 Jan 2026 1:49PM |
$0.400 |
$0.380 |
fallen by
5%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$94 |
Change of Director's Interest Notice
|
29 Jan 2026 1:47PM |
$1.265 |
$1.100 |
fallen by
13.04%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$94 |
Change of Director's Interest Notice
|
29 Jan 2026 1:47PM |
$1.265 |
$1.100 |
fallen by
13.04%
|
|
| Metrics Master Income Trust (MXT) ORDINARY UNITS FULLY PAID |
Financials |
$2,329 |
Daily Fund Update
|
29 Jan 2026 1:46PM |
$1.995 |
$1.900 |
fallen by
4.76%
|
|
| Ragnar Metals Limited (RAG) ORDINARY FULLY PAID |
Materials |
$11 |
Notification regarding unquoted securities - RAG
|
29 Jan 2026 1:46PM |
$0.035 |
$0.022 |
fallen by
37.14%
|
|
| Ragnar Metals Limited (RAG) ORDINARY FULLY PAID |
Materials |
$11 |
Cleansing Notice
|
29 Jan 2026 1:46PM |
$0.035 |
$0.022 |
fallen by
37.14%
|
|
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$324 |
Updated Goldfields DFS Presentation
|
29 Jan 2026 1:45PM |
$0.630 |
$0.295 |
fallen by
53.17%
|
|
BTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Brightstar Resources Limited aims to produce over 75,000 ounces of gold per annum.
- The upgraded Goldfields DFS estimates a pre-tax NPV of $606 million at a gold price of A$6,000 per ounce.
- Life-of-mine free cash flow is projected at $977 million over six years.
- First gold production is expected in the first half of 2027.
- The Laverton processing plant will handle all ore, removing the need for toll milling.
- The updated study de-risks the business model and improves economic outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$324 |
Updated Goldfields Feasibility Study
|
29 Jan 2026 1:45PM |
$0.630 |
$0.295 |
fallen by
53.17%
|
|
BTR - Price-sensitive ASX Announcement
Full Release
Key Points
- 505,000 ounces of gold targeted for mining.
- 457,000 ounces of gold expected to be recovered.
- Focus on Laverton and Menzies projects.
- Improvement in economic metrics compared to previous studies.
- Preparation for final investment decision by March 2026.
- Key deposits include Lord Byron, Cork Tree Well, and Lady Shenton.
- Ore processing planned for Brightstar's Laverton plant.
- On-going exploration and pre-development activities.
- Updated mineral resource and ore reserve estimates.
- Economic analysis includes mining, haulage, and processing costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ragnar Metals Limited (RAG) ORDINARY FULLY PAID |
Materials |
$11 |
Application for quotation of securities - RAG
|
29 Jan 2026 1:38PM |
$0.035 |
$0.022 |
fallen by
37.14%
|
|
| Mamba Exploration Limited (M24) ORDINARY FULLY PAID |
Materials |
$7 |
Pause in Trading
|
29 Jan 2026 1:37PM |
$0.040 |
$0.015 |
fallen by
62.50%
|
|
M24 - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX announced a pause in trading for Mamba Exploration Limited.
- The trading pause is for the security code M24.
- The pause is pending a further announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cue Energy Resources Limited (CUE) ORDINARY FULLY PAID |
Energy |
$77 |
Quarterly Activities Report
|
29 Jan 2026 1:35PM |
$0.120 |
$0.110 |
fallen by
8.33%
|
|
CUE - Price-sensitive ASX Announcement
Full Release
Key Points
- Total production steady at 1,680 barrels of oil equivalent per day.
- Strong cash balance of $11.2 million.
- Cash receipts were $9.9 million, affected by Mahato PSC schedule changes.
- Letter of Intent signed for long-term gas sales with Northern Territory Power and Water Corporation.
- Development planning underway for Mahato PSC Phase 3 and Paus Biru in Indonesia.
- Four new wells to be drilled in Australia by mid-2026.
- Exploring further production opportunities in New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anson Resources Limited (ASN) ORDINARY FULLY PAID |
Materials |
$74 |
Quarterly Activities and Cashflow Report
|
29 Jan 2026 1:29PM |
$0.065 |
$0.046 |
fallen by
28.68%
|
|
ASN - Price-sensitive ASX Announcement
Full Release
Key Points
- Green River Lithium Project advanced with new approvals for drilling.
- Partnership with POSCO and Utah State University for project and workforce development.
- Successful $14 million capital raising completed.
- Yellow Cat Project focused on optimizing drilling access and upgrading resources.
- Ajana Project continued with exploration planning and heritage negotiations.
- Strong financial position with $14.1 million in cash at quarter end.
- Estimated 18.6 quarters of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prominence Energy Limited (PRM) ORDINARY FULLY PAID |
Energy |
$2 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 1:28PM |
$0.004 |
$0.001 |
fallen by
75%
|
|
PRM - Price-sensitive ASX Announcement
Full Release
Key Points
- Prominence Energy completed the acquisition of the Gawler Natural Hydrogen Project.
- Final regulatory approval was received for the Change of Control of PEL 803.
- Prominence secured a strategic land position across the Gawler Craton.
- Significant technical de-risking was completed across PEL 803.
- Planning is advanced for an integrated geochemical survey in PEL 803.
- Prominence's cash flow from operating activities was negative.
- Net cash from financing activities included proceeds from equity securities.
- Prominence joined the Australian Clean Hydrogen and CCS Delegation to H2MEET Korea 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$18 |
Launch of Mayfield 360 Allied Health Services
|
29 Jan 2026 1:26PM |
$0.495 |
$0.240 |
fallen by
51.52%
|
|
MFD - Price-sensitive ASX Announcement
Full Release
Key Points
- Launch of Mayfield 360 Allied Health Services announced.
- Expansion includes Occupational Therapy, Speech Pathology, and Developmental Services.
- Focus on enhancing child outcomes and supporting families within the ECEC network.
- Strategy to diversify earnings and promote sustainable growth.
- Strong initial demand and enrolments noted.
- Aligns with opportunities in the Allied Health and NDIS sectors.
- Supported by demographic trends and government funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
- |
Dec25 Quarterly Activities Report
|
29 Jan 2026 1:25PM |
$0.024 |
$0.028 |
risen by
16.67%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of $750,000 placement and $107,730 entitlement offer for operational costs.
- Funding agreement extension of $12.6 million with Linlithgow Family Office for SRX-25 development.
- Manufacturing completion for IRX-211 and IRX-616a trial drugs.
- IRX-211 Phase 2 trial preparation, including site agreements and initiation visits.
- IRX-616a Phase 1 trial agreements and manufacturing finalization.
- Significant progress on SRX-25 Phase 1 trial protocol and investigator brochure.
- Dec25 clinical development costs totaled $485k with funding support from Clendon/LFO.
- Rebranding to Nexalis Therapeutics Limited pending shareholder approval.
- Aim to secure FDA NDA approvals using cost-effective regulatory pathways.
- Strategic focus on addressing unmet medical needs in pain and mental health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Voltaic Strategic Resources Ltd (VSR) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 1:18PM |
$0.045 |
$0.036 |
fallen by
20%
|
|
VSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Voltaic continued significant exploration efforts in Western Australia.
- Neo prospect shows promising results for Gallium and Rare Earth Elements.
- Net cash outflow of $154,000 from operating activities.
- Investing cash outflow totaled $556,000.
- Cash and cash equivalents stood at $1.845 million at quarter-end.
- Strategic focus on gallium's role in critical supply chains.
- No major financing activities occurred in the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
- |
Dec25 Appendix 4C Cash Flow Report
|
29 Jan 2026 1:16PM |
$0.024 |
$0.028 |
risen by
16.67%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow of $628,000 from operating activities
- Government grants and tax incentives received
- No significant cash flows from investing activities
- Net cash inflow of $894,000 from financing activities
- Funding facility of $38.5 million for clinical trials
- Cash and cash equivalents of $436,000 at quarter's end
- Unused finance facilities of $50,787,000 available
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Red Hill Minerals Limited (RHI) ORDINARY FULLY PAID |
Materials |
$305 |
Quarterly Activities, App 5B Cash Flow Report & Tenement
|
29 Jan 2026 1:15PM |
$4.950 |
$4.750 |
fallen by
4.04%
|
|
RHI - Price-sensitive ASX Announcement
Full Release
Key Points
- Royalty revenue for the quarter was $7.8 million.
- Cash balance at quarter-end was $61.3 million.
- Dividend paid was $4.2 million with exploration expenditure of $2.7 million.
- Significant diamond drilling program completed at Broken Hill Project.
- Successful results from the Anabama Project diamond drill program.
- Net cash from operating activities was $5.4 million.
- Focus on exploration and evaluation investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$46 |
Neurizon secures $6million R&D Tax Incentive Rebate
|
29 Jan 2026 1:12PM |
$0.084 |
$0.060 |
fallen by
28.57%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon secured a $6 million cash rebate under Australia's R&D Tax Incentive program for FY2025.
- The rebate reflects a 48.5% return on eligible R&D activities, including foreign expenditures.
- Funds will support the HEALEY ALS Platform Trial and expand the NUZ-001 pipeline.
- The rebate is part of a funding strategy announced in December 2025.
- Neurizon aims to advance treatments for ALS and broader neurodegenerative diseases.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$37 |
Application for quotation of securities - AR9
|
29 Jan 2026 1:08PM |
$0.105 |
$0.076 |
fallen by
27.62%
|
|
Call 1300 880 160
Start a chat
Schedule a call
